Interestingly, the fact that high estrogen response early score was associated with better prognosis in metastatic tumors and the hazard ratio of the score was higher than that of ESR1 expression indicated that the score may be useful as a predictive biomarker for metastatic breast cancer. Here, ESR1 is linked to metastatic neoplasm.